Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity

Rouven Hoefflin, Bernd Lahrmann, Gregor Warsow, Daniel Hübschmann, Cathleen Spath, Britta Walter, Xin Chen, Luisa Hofer, Stephan Macher‐Goeppinger, Yanis Tolstov, Nina Korzeniewski, Anette Duensing, Carsten Grüllich, Dirk Jäger, Sven Perner, Gita Schönberg, Joanne Nyarangi‐Dix, Sanjay Isaac, Gencay Hatiboglu, Doğu Teber, Boris Hadaschik, Sascha Pahernik, Wilfried Roth, Roland Eils, Matthias Schlesner, Holger Sültmann, Markus Hohenfellner, Niels Grabe, Stefan DuensingNature Communications 2016 · DOI

Abstract

Intratumoural heterogeneity (ITH) is a major cause of cancer-associated lethality. Extensive genomic ITH has previously been reported in clear cell renal cell carcinoma (ccRCC). Here we address the question whether ITH increases with malignant progression and can hence be exploited as a prognostic marker. Unexpectedly, precision quantitative image analysis reveals that the degree of functional ITH is virtually identical between primary ccRCCs of the lowest stage and advanced, metastatic tumours. Functional ITH was found to show a stage-independent topological pattern with peak proliferative and signalling activities almost exclusively in the tumour periphery. Exome sequencing of matching peripheral and central primary tumour specimens reveals various region-specific mutations. However, these mutations cannot directly explain the zonal pattern suggesting a role of microenvironmental factors in shaping functional ITH. In conclusion, our results indicate that ITH is an early and general characteristic of malignant growth rather than a consequence of malignant progression.

Introduction

Intratumoural heterogeneity (ITH)—the mosaic of distinct cell populations within a single tumor—is a primary driver of drug resistance and treatment failure. In clear cell renal cell carcinoma (ccRCC), while genomic ITH is well-documented, it remained unclear whether this diversity scales with disease progression. If ITH increases as a tumor advances, it could serve as a critical prognostic marker. This study investigates the relationship between tumor stage and functional/genomic diversity, exploring whether ITH is a product of time or spatial architecture.

Methods and Materials

The researchers analyzed 30 ccRCC tumors across three prognostic subgroups: small localized (pT1M0), advanced/metastatic (pT3/4), and small metastatic (pT1M1) tumors.

Quantitative Imaging Workflow

The study utilized a precision quantitative imaging pipeline to move beyond subjective pathology scoring. Whole-slide digital scans were processed through a four-step workflow:

  1. Immunohistochemistry (IHC): Staining for five key biomarkers.
  2. Grid Application: Overlaying a virtual 1mm² grid.
  3. Quantification: Automated pixel-level quantification of markers within each grid square, excluding benign tissue.
  4. Heatmap Creation: Generating spatial maps of biomarker intensity.
The four-step quantitative imaging workflow used to map functional heterogeneity across whole tumor sections.

Biodiversity and Genomic Analysis

To measure diversity, the team applied ecological indices (Shannon and Inverse Simpson) to the biomarker data. Regional whole-exome sequencing (WES) was also performed on 8 cases, comparing macro-dissected central versus peripheral zones to identify region-specific mutations.

Results

Functional ITH is Stage-Independent

The most striking finding was that functional ITH scores (including biodiversity indices and standard deviation of marker expression) showed no statistical difference between low-stage and high-stage tumors ($P > 0.05$). This indicates that even small, early-stage tumors possess the same level of functional "chaos" as advanced metastatic ones.

The Peripheral Growth Niche

The study identified a consistent topological pattern across the cohort. Peak expression of markers for proliferation (Ki-67) and signaling (phospho-mTOR, phospho-S6RP) was statistically confirmed to reside in the tumor periphery ($P < 0.05$).

Representative IHC staining for the five biomarkers analyzed: HIF-1α, HIF-2α, Phospho-mTOR, Phospho-S6RP, and Ki-67.

While WES identified 88 region-specific functional mutations, these genetic changes did not consistently correlate with the aggressive behavior observed at the tumor's edge. This suggests that the microenvironment at the periphery—characterized by better nutrient access and physical space for expansion—is the primary driver of this functional niche.

Discussion and Clinical Implications

These findings suggest that ITH is a "truncal" feature of ccRCC, appearing early in tumor development rather than accumulating as a late-stage complication. This has profound implications for clinical practice:

  • Biopsy Strategy: A single biopsy from the tumor center likely underestimates the malignancy and evolutionary potential of the tumor, as the most aggressive cells are concentrated at the periphery.
  • Prognostic Value: Since ITH does not scale with stage, its absolute "amount" may not be a reliable prognostic marker for progression in ccRCC.
  • Niche-Driven Evolution: The dominance of microenvironmental factors over specific mutations in shaping the peripheral niche suggests that targeting the tumor's interface with host tissue may be as important as targeting specific genetic clones.

Future work is needed to elucidate the exact metabolic and physical mechanisms (e.g., oxygen tension, "empty site" expansion) that define the peripheral growth niche.

Summary updated

Abstract

Intratumoural heterogeneity (ITH) is a major cause of cancer-associated lethality. Extensive genomic ITH has previously been reported in clear cell renal cell carcinoma (ccRCC). Here we address the question whether ITH increases with malignant progression and can hence be exploited as a prognostic marker. Unexpectedly, precision quantitative image analysis reveals that the degree of functional ITH is virtually identical between primary ccRCCs of the lowest stage and advanced, metastatic tumours. Functional ITH was found to show a stage-independent topological pattern with peak proliferative and signalling activities almost exclusively in the tumour periphery. Exome sequencing of matching peripheral and central primary tumour specimens reveals various region-specific mutations. However, these mutations cannot directly explain the zonal pattern suggesting a role of microenvironmental factors in shaping functional ITH. In conclusion, our results indicate that ITH is an early and general characteristic of malignant growth rather than a consequence of malignant progression.
BibTeX
@inproceedings{hoefflin2016spatial,
  author = {Rouven Hoefflin and Bernd Lahrmann and Gregor Warsow and Daniel Hübschmann and Cathleen Spath and Britta Walter and Xin Chen and Luisa Hofer and Stephan Macher‐Goeppinger and Yanis Tolstov and Nina Korzeniewski and Anette Duensing and Carsten Grüllich and Dirk Jäger and Sven Perner and Gita Schönberg and Joanne Nyarangi‐Dix and Sanjay Isaac and Gencay Hatiboglu and Doğu Teber and Boris Hadaschik and Sascha Pahernik and Wilfried Roth and Roland Eils and Matthias Schlesner and Holger Sültmann and Markus Hohenfellner and Niels Grabe and Stefan Duensing},
  title = {{Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity}},
  booktitle = {Nature Communications},
  year = {2016},
  doi = {10.1038/ncomms11845},
}
Figure